Comparison of 56 patients who had post-transplant histology suitable for inclusion in the study and 45 patients who did not
| Patients without histology | Patients with histology | p Value | |
|---|---|---|---|
| Data are median (range) or number (%). | |||
| HBsAg, hepatitis B virus surface antigen. | |||
| n | 45 | 56 | |
| Follow up (months) | 12 (0–100) | 42 (10–145) | <0.001 |
| Death | 16 (36%) | 4 (7%) | <0.001 |
| Death from liver failure | 1 | 2 | 0.4 |
| Age at transplant (y) | 49 (33–65) | 48 (28–67) | 0.4 |
| Males | 35 (78%) | 45 (80%) | 0.7 |
| Caucasian | 27 (60%) | 32 (57%) | 0.8 |
| Cyclosporin/tacrolimus | 45/0 | 49/7 | 0.01 |
| Treated rejection | 16 (36%) | 21 (37%) | 0.8 |
| More than 1 rejection episode | 2 | 3 | 0.8 |
| HBsAg positive | 1 | 5 | 0.15 |
| Cold ischaemic time (min) | 709 (221–1140) | 782 (201–1280) | 0.4 |
| Warm ischaemic time (min) | 50 (33–79) | 47 (25–76) | 0.1 |
| Donor age | 45 (14–64) | 42 (15–67) | 0.6 |